耳鼻咽喉科領域における細菌感染症に対するT-1220の効果

DOI Web Site

書誌事項

タイトル別名
  • CLINICAL TRIAL OF T-1220 IN THE TREATMENT OF ACUTE OR CHRONIC EAR, NOSE AND THROAT DISEASES
  • ジビ インコウカ リョウイキ ニ オケル サイキン カンセンショウ ニ タイス

この論文をさがす

抄録

17 cases with ear, nose and throat diseases were treated by intravenous injection or intravenous continuous infusion of 2 or 4 g of T-1220 per day.<BR>4 cases with acute otitis media were cured rapidly by this therapy. 3 cases with chronic otitis media infected by Proteus mirabilis could not be cured by the intravenous injection of 1-2 g of T-1220 for 3-46 days, but another one with otitis media infected by Pseudomonas aeruginosa could be cured by the intravenous injection of 2-4 g of T-1220 per day for 20 days. In the later case, however, attack of high fever appeared as the side effect, and disappeared after discontinue of the injection of this drug.<BR>The other 9 cases with various acute or chronic upper or lower airway diseases were almost cured by intravenous injection of 2-4 g of T-1220 per day for 10-2 days, excepting 2 cases.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ